Debate

DOI: 10.4244/EIJ-E-24-00034

Concomitant left atrial appendage occlusion in patients undergoing mitral transcatheter edge-to-edge repair: pros and cons

Fabian Nietlispach1, MD, PhD; John G. Webb2, MD; Ole De Backer3, MD, PhD

Introduction

Patients with mitral regurgitation (MR) undergoing mitral transcatheter edge-to-edge repair (M-TEER) might also present indications for left atrial appendage occlusion (LAAO). While concomitant interventions are common in cardiac surgery, their role in interventional cardiology remains less clear. In particular, concomitant M-TEER and LAAO has the advantage of reducing the lifelong bleeding risk while avoiding repeat interventions. However, this combined strategy introduces clinical and procedural complexities that necessitate a careful evaluation of its benefits and drawbacks. Notably, apart from the presence of atrial fibrillation (AF) in many patients undergoing M-TEER, determining the indication and suitability for LAAO requires a thorough assessment encompassing clinical factors (e.g., bleeding risk, residual determinants of cardioembolism), procedural considerations (e.g., precise location of transseptal puncture, procedural duration), and practical aspects (e.g., reimbursement). Based on current knowledge, it is not definitively clear whether concomitant LAAO should be performed in patients undergoing M-TEER.

Pros

Fabian Nietlispach, MD, PhD; John G. Webb, MD

In AF patients, LAAO offers a similar protection from cardioembolic events as direct oral anticoagulants (DOACs) but reduces the risk of non-procedural clinically...

Sign in to read
the full article

Forgot your password?
No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Volume 20 Number 16
Aug 19, 2024
Volume 20 Number 16
View full issue


Key metrics

Suggested by Cory

CLINICAL RESEARCH

10.4244/EIJ-D-16-00784 Mar 20, 2017
Feasibility of concomitant MitraClip and left atrial appendage occlusion
Kuwata S et al
free

Expert Review

10.4244/EIJ-D-23-00700 Feb 19, 2024
Evolving indications for transcatheter mitral edge-to-edge repair
Shuvy M and Maisano F
free

State-of-the-Art

10.4244/EIJ-D-22-00725 Jan 23, 2023
Mitral valve transcatheter edge-to-edge repair
Hausleiter J et al
free

Editorial

10.4244/EIJ-E-24-00003 Feb 19, 2024
Between Scylla and Charybdis in atrial functional mitral regurgitation
Denti P
free

Editorial

10.4244/EIJ-E-24-00047 Oct 21, 2024
Mitral valve edge-to-edge repair under scrutiny: what can we learn from transoesophageal echocardiographic follow-up?
Hausleiter J and Stolz L
free

10.4244/EIJV11SWA29 Sep 17, 2015
TAVI and concomitant procedures: from PCI to LAA closure
Taramasso M et al
free

Original Research

10.4244/EIJ-D-24-00297 Oct 21, 2024
Findings from transoesophageal echocardiographic follow-up after mitral transcatheter edge-to-edge repair
Bartkowiak J et al
Trending articles
151.68

State-of-the-Art

10.4244/EIJ-D-22-00776 Apr 3, 2023
Computed tomographic angiography in coronary artery disease
Serruys PW et al
free
55.9

Clinical research

10.4244/EIJ-D-22-00621 Feb 20, 2023
Long-term changes in coronary physiology after aortic valve replacement
Sabbah M et al
free
54.9

Expert review

10.4244/EIJ-D-21-01010 Jun 24, 2022
Device-related thrombus following left atrial appendage occlusion
Simard T et al
free
43.75

Clinical Research

10.4244/EIJ-D-21-01091 Aug 5, 2022
Lifetime management of patients with symptomatic severe aortic stenosis: a computed tomography simulation study
Medranda G et al
free
39.95

Clinical research

10.4244/EIJ-D-22-00558 Feb 6, 2023
Permanent pacemaker implantation and left bundle branch block with self-expanding valves – a SCOPE 2 subanalysis
Pellegrini C et al
free
38.95

State-of-the-Art

10.4244/EIJ-D-23-00912 Oct 7, 2024
Optical coherence tomography to guide percutaneous coronary intervention
Almajid F et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved